iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes
Author(s) -
Per Bäckman,
Antonio Cabal,
Andrew R. Clark,
Carsten Ehrhardt,
Ben Forbes,
Jayne E. Hastedt,
Anthony J. Hickey,
Günther Hochhaus,
Wenlei Jiang,
Stavros C. Kassinos,
Philip J. Kuehl,
David Prime,
YoenJu Son,
Simon Teague,
Ulrika Tehler,
Jennifer Wylie
Publication year - 2022
Publication title -
molecular pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 127
eISSN - 1543-8392
pISSN - 1543-8384
DOI - 10.1021/acs.molpharmaceut.2c00112
Subject(s) - biopharmaceutics , biopharmaceutics classification system , drug , pharmacology , pharmacokinetics , computer science , bioequivalence , chemistry , medicine , in vitro , pharmacognosy , biochemistry , biological activity
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom